Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis

Main Article Content

CEM Griffiths
KA Papp
M Song
B Randazzo
S Li
YK Shen
C Han
A Blauvelt



Abstract not available.


Disclosures: Study sponsored by Janssen.


Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 > >>